This compound is a pharmaceutical intermediate featuring both acetal and carbamate functional groups, specifically a benzyl carbamate derivative of a cyclopenta-dioxolol. Its structure is characterized by multiple stereocenters and a bicyclic system with hydroxyl and ether moieties, making it a building block for complex molecule synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 274693-53-7
2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol
pharmaceutical intermediate
3,4-Diethoxyphenylacetonitrile
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[(1S)-1-[bis(4-methoxyphenyl)-phenyl-methoxy]ethyl]-5-(2,4-dioxopyrimidin-1-yl)-4-methoxy-tetrahydrofuran-3-yl]oxy-(diisopropylamino)phosphanyl]oxypropanenitrile
pharmaceutical intermediate
L-Leucine tert-butyl ester hydrochloride
pharmaceutical intermediate
Benzyl((3aR,4S,6R,6aS)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate
research compound
N-[(3aS,4R,6S,6aR)-Tetrahydro-6-(2-hydroxyethoxy)-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamic acid phenylmethyl ester
pharmaceutical intermediate
Ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
pharmaceutical intermediate
benzyl N-[(3aR,4S,6R,6aS)-4-hydroxy-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]carbamate
NZWQSYTXYZYUNP-QONRVRNRSA-N
CC1(O[C@H]2[C@@H](C[C@@H]([C@H]2O1)O)NC(=O)OCC3=CC=CC=C3)C.CC1(O[C@H]2[C@@H](C[C@@H]([C@H]2O1)O)NC(=O)OCC3=CC=CC=C3)C
—